STOCK TITAN

Orchid Is Cap Inc SEC Filings

ORC NYSE

Welcome to our dedicated page for Orchid Is Cap SEC filings (Ticker: ORC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Orchid Island Capital, Inc. filings document a mortgage REIT focused on leveraged investments in Agency RMBS. The company’s Form 8-K reports record quarterly results, estimated book value, RMBS portfolio characteristics, monthly dividend declarations, realized and unrealized results on RMBS and derivative instruments, interest rate swap activity, liquidity and repurchase agreement financing.

Proxy filings cover board matters, executive compensation and shareholder voting for the Maryland corporation. The filing record also reflects the company’s REIT distribution framework, common-stock dividend disclosures, externally managed structure through Bimini Advisors, LLC, and recurring risk and governance subjects tied to mortgage securities, leverage and interest-rate exposure.

Rhea-AI Summary

BlackRock, Inc. filed Amendment No. 4 to Schedule 13G reporting its beneficial ownership of Orchid Island Capital, Inc. (ORC) common stock. As of 09/30/2025, BlackRock reported 11,258,423 shares, representing 7.7% of the class.

BlackRock reported sole voting power over 10,982,940 shares and sole dispositive power over 11,258,423 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

The filing notes that various persons have rights to dividends or sale proceeds relating to the shares, and that no one person’s interest exceeds five percent of the total outstanding common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Orchid Island Capital (ORC) reported preliminary third‑quarter metrics and declared its monthly dividend. The company estimates book value of $7.33 per share as of September 30, 2025 and estimated GAAP net income of $0.53 per share for the quarter, which includes $0.37 per share of net realized and unrealized gains on RMBS and derivatives. These figures are preliminary and subject to review by the independent auditor.

The Board declared an October 2025 dividend of $0.12 per share, payable on November 26, 2025 to shareholders of record on October 31, 2025 (ex‑dividend date October 31, 2025).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
current report
-
Rhea-AI Summary

Frank P. Filipps, a director of Orchid Island Capital, Inc. (ORC), reported a Form 4 showing he was granted 3,566 deferred stock units on 10/01/2025. Each deferred stock unit represents a right to receive one share of the company’s common stock and the units are stated to be 100% vested. The deferred units do not become payable until the earlier of a change of control or the reporting person’s death, disability, or separation from service as a director. After this grant, the Form 4 reports total beneficial ownership of 43,256 shares. The filing was signed on 10/02/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Orchid Island Capital director Paula Morabito reported acquiring 3,566 deferred stock units on 10/01/2025. Each unit equals one share of common stock and the units are 100% vested, but payment is deferred until the earlier of a change of control, the reporting person's death or disability, or separation from service as a director. After this transaction, the reporting person beneficially owns 45,067 shares of Orchid Island Capital common stock. The filing is a Form 4 reporting an insider non-derivative acquisition of deferred compensation units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

W. Coleman Bitting, a director of Orchid Island Capital, Inc. (ORC), reported receiving 3,566 deferred stock units on 10/01/2025. Each unit represents a right to one share of the company's common stock and carries a stated price of $0. After this grant, Mr. Bitting beneficially owns 43,256 shares (direct). The deferred stock units are fully vested but are payable only upon a specified triggering event: the earlier of a change of control or the reporting person’s death, disability, or separation from service as a director. The Form is signed on 10/02/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ava L. Parker, a director of Orchid Island Capital, Inc. (ORC), reported three grants of deferred stock units on 09/30/2025 and 10/01/2025.

The filings show 1,553 DSUs issued on 09/30/2025 in lieu of the monthly dividend at an attributable value of $6.91 per unit, plus two grants on 10/01/2025 of 3,566 DSUs (no price listed) and 2,050 DSUs granted in lieu of cash compensation with an attributable value of $7.01 per unit. Following these transactions the reporting person beneficially owned 96,636 shares.

The DSUs are fully vested but payable only upon a change of control or the reporting person's death, disability, or separation from service as a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Orchid Island Capital director and CFO G. Hunter Haas, IV reported transactions on 09/26/2025 reflecting the vesting of Performance Units and a related withholding sale. 3,031.72 Performance Units vested and were converted into 3,031 shares of common stock (cash paid for fractional shares). To satisfy tax withholding on the vesting, 1,133 shares were transferred back to the issuer at a closing price of $6.99 per share. After these transactions the reporting person directly beneficially owned 75,600 shares of common stock and held performance-unit-based derivative interests equal to 3,031.72 underlying shares, with 13,851.11 derivative securities reported as beneficially owned following the transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Orchid Island Capital director and CEO Robert E. Cauley reported equity activity on 09/26/2025. 3,694 shares were added to his holdings through the vesting of performance units granted in 2023 and 2024, issued at no cash price; fractional shares were cashed out based on the 09/25/2025 closing price. To satisfy tax withholding obligations, Mr. Cauley transferred 742 shares back to the company at a reported price of $6.99 per share. After these transactions, he beneficially owns 145,296 common shares and holds 16,186.92 shares underlying remaining performance units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Orchid Island Capital, Inc. filed a Current Report on Form 8-K that discloses an exhibit: a press release dated September 8, 2025. The filing identifies the company as a Maryland corporation trading common stock under the ticker ORC on the NYSE and states the exhibit is included under Item 9.01 (Financial Statements and Exhibits). The report is signed by Robert E. Cauley, Chairman and Chief Executive Officer. No financial tables, earnings figures, transactions, or additional narrative are included in this filing; it functions primarily to attach the press release as an exhibit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
current report
Rhea-AI Summary

Ava L. Parker, a director of Orchid Island Capital, Inc. (ORC), reported receipt of 1,493 deferred stock units on 08/28/2025 issued in lieu of her monthly dividend election. Each deferred stock unit equals one share of the issuer's common stock and the filing reports 89,467 shares beneficially owned by Ms. Parker after the transaction. The units are fully vested but are not payable until the earlier of a change of control, death, disability, or separation from service as a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Orchid Is Cap (ORC) SEC filings are available on StockTitan?

StockTitan tracks 63 SEC filings for Orchid Is Cap (ORC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Orchid Is Cap (ORC)?

The most recent SEC filing for Orchid Is Cap (ORC) was filed on October 17, 2025.